SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 07, 2023 at 06:35 pm EDT
Share
SYN-TECH Chem. & Pharm. Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 245.14 million compared to TWD 260.48 million a year ago. Net income was TWD 67.54 million compared to TWD 104.1 million a year ago. Basic earnings per share from continuing operations was TWD 1.51 compared to TWD 2.33 a year ago. Diluted earnings per share from continuing operations was TWD 1.51 compared to TWD 2.33 a year ago.
For the six months, sales was TWD 512.42 million compared to TWD 456.44 million a year ago. Net income was TWD 133.06 million compared to TWD 158.65 million a year ago. Basic earnings per share from continuing operations was TWD 2.98 compared to TWD 3.56 a year ago. Diluted earnings per share from continuing operations was TWD 2.98 compared to TWD 3.56 a year ago.
SYN-TECH Chem. & Pharm. Co., Ltd. is a Taiwan-based company principally engaged in the production, processing and distribution of active pharmaceutical ingredients (APIs). The Companyâs main products consist of muscle relaxants, local anesthetics, cardiovascular agents, antipyretics, analgesics and anti-inflammatory drugs, antimicrobials, spirit stabilizers, intermediates and others. It is also engaged in the pharmaceutical agency business. The Company distributes its products within Taiwan market and to overseas markets, including Asia, Europe, the Americas and Africa.
SYN-TECH CHEM. & PHARM. CO., LTD. 
